Larimar Therapeutics, Inc. Stock Forecast

Larimar Therapeutics, Inc. stock upgraded to Sell Candidate.
(Updated on Apr 26, 2024)

LRMR Signals & Forecast

There are mixed signals in the stock today. The Larimar Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $7.58. On a fall, the stock will find some support from the short-term average at $6.43. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Thursday, February 15, 2024, and so far it has fallen -51.51%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Larimar Therapeutics, Inc. stock

Larimar Therapeutics, Inc. finds support from accumulated volume at $6.38 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.270 between high and low, or 4.29%. For the last week the stock has had daily average volatility of 5.88%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (LRMR) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Larimar Therapeutics, Inc. to open at $6.43, and during the day (based on 14 day Average True Range), to move between $5.91 and $6.97, which gives a possible trading interval of +/-$0.535 (+/-8.30%) up or down from last closing price. If Larimar Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 16.61% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $6.38 (0.93%) than the resistance at $7.72 (19.88%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Larimar Therapeutics, Inc. stock A Buy?

Larimar Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.716 Sell Candidate Upgraded

Predicted Opening Price for Larimar Therapeutics, Inc. of Monday, April 29, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.